It looks like nothing was found at this location. Maybe try one of the links below or a search?
- Windlas Healthcare Invests $2 Million in Working Capital to Support Marina Biotech’s Manufacturing Initiatives
- Marina Biotech Announces 1-for-10 Reverse Stock Split in Preparation for Proposed Up-Listing of its Common Stock to the NASDAQ Capital Market
- Marina Biotech Announces Binding Letter of Intent for the Sale of its DiLA2 Delivery Platform
- Marina Biotech Acquires DyrctAxess™ Technology Platform to Support Sales and Marketing of Prestalia®
- Marina Biotech Announces a License Agreement to SMARTICLES and CRN platforms for Antisense DNA therapeutics
Most Used Categories
Try looking in the monthly archives. 🙂